The Trading Radar highlights key earnings and economic announcements for the next trading session:Before Markets Open:
Earnings:AECOM Technology (NYSE: ACM) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Needham & Company Reiterates Buy as Radisys Corp's (RSYS) 4Q Results Come In-Line with Preannouncement February 10, 2016 2:14 PM UBS Remains Sidelined Following Moelis & Company's (MC) 4Q EPS Beat February 10, 2016 10:41 AM UBS Cuts Price Target on HCP, Inc. (HCP) as HCR ManorCare (HCRMC) Faces Difficulties February 10, 2016 10:36 AM UBS Remains Bullish as Civitas Solutions (CIVI) Reaffirms Full Year Guidance February 10, 2016 10:09 AM Leerink Partners Reiterates Outperform on WellCare Health Plans (WCG) Following In-Line 4Q February 10, 2016 9:09 AM Piper Jaffray Reiterates Outperform Following Catalent's (CTLT) 2Q Beat February 10, 2016 9:03 AM Piper Jaffray Cuts Price target Following Assurant's (AIZ) Weak 4Q February 10, 2016 8:44 AM Leerink Partners Cuts Price Target on Regeneron (REGN) as Eylea Growth Slows February 10, 2016 8:30 AM Ruckus Wireless (RKUS) Attributes Revenue Miss to E-Rate Related Deal; Needham & Company Reiterates Buy February 10, 2016 8:24 AM Mizuho Securities Remains Neutral on HCP, Inc. (HCP) - Cuts PT to $26 February 10, 2016 8:15 AM Mizuho Securities Cuts Price Target as Demandware (DWRE) Expands Low End of Bookings Guidance February 10, 2016 8:03 AM BMO Capital Cuts Price Target on Disney (DIS) as Affiliate Fee Sentiment Remains Negative February 10, 2016 7:39 AM FBR Capital Reiterates Underperform as Akamai Technologies' (AKAM) Weak Guide is Driven by Aggressive Pricing and Revenue Declines February 10, 2016 7:11 AM RBC Capital Raises Price Target on Benchmark Electronics (BHE) Following a Strong 4Q February 9, 2016 3:51 PM Topeka Capital Downgrades RetailMeNot Inc. (SALE) to HoldFebruary 9, 2016 2:34 PM Leerink Partners Continues to View CVS Health (CVS) as a High Quality Stock - Reiterates Outperform February 9, 2016 2:07 PM Baird Cuts Price Target on Regeneron (REGN) as Late Stage Trials Hit Operating Costs - Reiterates Outperform February 9, 2016 1:45 PM Baird Remains Neutral and Cuts Price Target on CDW (CDW) Following an In-Line 4Q February 9, 2016 1:11 PM